Vitality Biopharma, Inc.
SEC CIK 1438943 · stvf.ob · last insider filing 2026-06-16
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Celeste Richard F | Director | filed 2019 - 2026 |
| Feighan Edward F | Director · Executive Chairman | filed 2018 - 2026 |
| Cavanaugh Michael R. | Director · Chief Executive Officer | filed 2018 - 2026 |
| Maida Anthony E III | Director | filed 2012 - 2019 |
| Dhillon Avtar S | Director · President,CEO,CFO,Sec and Tres | filed 2011 - 2019 |
| Brooke Robert T. | Director · VP of Business Devevlopment | filed 2011 - 2019 |
| Chen Tao | Director · President | filed 2008 - 2011 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Missal Patricia Ann | Chief Financial Officer | filed 2024 - 2026 |
| Mckilligan Richard | Chief Financial Officer | filed 2019 - 2023 |
| Zipp Brandon Joel | Chief Science Officer | filed 2020 - 2023 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.